We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
+24.15%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$153M
AUM Growth
+$25.8M
Cap. Flow
+$5.34M
Cap. Flow %
3.49%
Top 10 Hldgs %
66%
Holding
76
New
20
Increased
15
Reduced
12
Closed
14

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.3M
2
ASTS icon
AST SpaceMobile
ASTS
+$3.79M
3
ABVX
Abivax
ABVX
+$2.95M
4
PVLA
Palvella Therapeutics
PVLA
+$2.73M
5
ARWR icon
Arrowhead Research
ARWR
+$2.04M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$5.05M
2
KRYS icon
Krystal Biotech
KRYS
+$4.62M
3
CELC icon
Celcuity
CELC
+$3.41M
4
AAOI icon
Applied Optoelectronics
AAOI
+$3.23M
5
ALMS
Alumis Inc
ALMS
+$2.85M

Sector Composition

Rank Sector Weight
1 Healthcare 63.9%
2 Energy 17.83%
3 Technology 7.89%
4 Consumer Discretionary 4.98%
5 Industrials 1.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KURA icon
26
Kura Oncology
KURA
$817M
$975K 0.64%
88,900
+15,000
+20% +$142K
PRAX icon
27
Praxis Precision Medicines
PRAX
$8.9B
$904K 0.59%
2,700
– –
AAOI icon
28
Applied Optoelectronics
AAOI
$10.3B
$889K 0.58%
6,000
-19,900
-77% -$3.23M
CCJ icon
29
Cameco
CCJ
$41.1B
$856K 0.56%
+8,400
New +$942K
GLUE icon
30
Monte Rosa Therapeutics
GLUE
$1.32B
$847K 0.55%
35,000
+12,500
+56% +$236K
RGNX icon
31
Regenxbio
RGNX
$672M
$809K 0.53%
67,500
+11,500
+21% +$95.4K
MLYS icon
32
Mineralys Therapeutics
MLYS
$2.37B
$758K 0.5%
+28,100
New +$771K
GBTC icon
33
Grayscale Bitcoin Trust
GBTC
$9.74B
$701K 0.46%
15,400
– –
VIR icon
34
Vir Biotechnology
VIR
$1.54B
$655K 0.43%
64,300
– –
PALI icon
35
Palisade Bio
PALI
$368M
$643K 0.42%
307,500
+50,000
+19% +$98.4K
PLTR icon
36
Palantir
PLTR
$380B
$642K 0.42%
+5,500
New +$750K
ON icon
37
ON Semiconductor
ON
$29.9B
$567K 0.37%
+6,000
New +$615K
HCC icon
38
Warrior Met Coal
HCC
$4.45B
$487K 0.32%
6,000
– –
CRGY icon
39
Crescent Energy
CRGY
$3.63B
$442K 0.29%
45,000
– –
MBX
40
MBX Biosciences
MBX
$3.21B
$442K 0.29%
8,000
-1,000
-11% -$34.9K
KEEL
41
Keel Infrastructure Corp
KEEL
$2.37B
$428K 0.28%
+74,500
New +$320K
CMPS
42
Compass Pathways
CMPS
$1.83B
$425K 0.28%
30,000
+14,500
+94% +$147K
CRVS icon
43
Corvus Pharmaceuticals
CRVS
$1.17B
$403K 0.26%
+27,000
New +$375K
ACOG
44
Alpha Cognition
ACOG
$186M
$372K 0.24%
51,500
– –
KYTX icon
45
Kyverna Therapeutics
KYTX
$464M
$356K 0.23%
40,000
+10,000
+33% +$88.8K
AXTI icon
46
AXT Inc
AXTI
$4.49B
$353K 0.23%
+4,900
New +$441K
INFQ
47
Infleqtion Inc
INFQ
$2.37B
$333K 0.22%
+25,000
New +$344K
SRRK icon
48
Scholar Rock
SRRK
$5.74B
$330K 0.22%
6,000
-4,800
-44% -$232K
PATH icon
49
UiPath
PATH
$7.16B
$326K 0.21%
30,000
-20,000
-40% -$214K
ANL
50
Adlai Nortye
ANL
$842M
$311K 0.2%
+27,000
New +$329K
1
2
3

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, ACT Capital Management held 76 positions worth $153M, up 20% from $127M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

ACT Capital Management deployed $5.34M of net new capital in Q2 2026, opening 20 new positions and adding to 15 existing holdings. Its largest new stake was Tesla: 10,800 shares worth $4.54M.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 62% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Amazon, an estimated $5.05M trimmed.

  • ACT Capital Management's largest Q2 2026 buy was Tesla: 10,800 shares worth $4.54M.
  • ACT Capital Management added most to Abivax in Q2 2026, an estimated $2.95M increase.
  • ACT Capital Management's biggest Q2 2026 reduction was Amazon, cutting an estimated $5.05M.
  • ACT Capital Management fully exited STAAR Surgical in Q2 2026, selling an estimated $1.04M.
  • ACT Capital Management's ten largest holdings make up 66% of its $153M portfolio in Q2 2026.
  • ACT Capital Management opened 20 new positions and closed 14 in Q2 2026.
  • ACT Capital Management's portfolio value rose 20% quarter-over-quarter to $153M.

Based on ACT Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.